Pain syndromes after missile-caused peripheral nerve lesions: part 2--treatment.
OBJECTIVE
To analyze treatment procedures and treatment outcomes of painful missile-caused nerve injuries and factors influencing the outcome.


METHODS
The study included 326 patients with clinically significant pain syndromes, including complex regional pain syndrome Type II, deafferentation pain, reinnervation pain, and neuralgic pain. Treatment modalities included drug therapy, nerve surgery, sympatholysis, and dorsal root entry zone operation. Pain intensity was assessed before and after the treatment using a visual analog scale, and treatment outcome was defined as successful (pain relief >70%), fair (pain relief between 50 and 69%), or poor (pain relief <50%). The outcome was compared between different pain syndromes and different treatment modalities.


RESULTS
A successful outcome was achieved in 28.6% of patients with deafferentation pain, in 76.9% of patients with complex regional pain syndrome Type II, and in 87.9 to 100% of patients with other pain syndromes (P = 0.002). Each type of pain syndrome required a specific treatment algorithm, but average pain relief was similar for all definitive treatment modalities (range, 81-88%; P > 0.05). Ten factors were found to significantly influence the treatment outcome, but only three factors were independent predictors of a successful outcome: type of pain syndrome (P < 0.001), severity of nerve injury (P < 0.001), and absence of pain paroxysms (P = 0.03).


CONCLUSIONS
The treatment outcome of painful nerve injury depends on several factors, including the type of pain syndrome, severance of nerve injury, and absence of pain paroxysms. Drug therapy (carbamazepine, amitriptyline, or gabapentin) should be recommended, at least as a part of treatment, for patients with reinnervation pain, deafferentation pain, and complex regional pain syndrome Type II. Nerve surgery should be recommended for patients with posttraumatic neuralgia, either as the first treatment choice (acute nerve compression or intraneural foreign particles) or after unsuccessful pharmacological treatment (other causes of neuralgic pain).
Roganovic
Zoran
Z
Neurosurgical Department, Military Medical Academy, Belgrade, Serbia. roganovic@yubc.net
Mandic-Gajic
Gordana
G
D000293:Adolescent; D000328:Adult; D002648:Child; D015897:Comorbidity; D020918:Complex Regional Pain Syndromes / Q000453:epidemiology* / Q000628:therapy*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D008889:Military Personnel / Q000706:statistics & numerical data*; D059348:Peripheral Nerve Injuries; D013577:Syndrome; D020196:Trauma, Nervous System / Q000453:epidemiology*; D016896:Treatment Outcome; D014857:Warfare; D014950:Wounds, Penetrating / Q000453:epidemiology*; D015022:Yugoslavia / Q000453:epidemiology